Table 2.
Infection site, pathogen identification.
| Infection Site, Pathogen Identification | ||||
|---|---|---|---|---|
| Procedure | Study, Year | Site of Infection by Region (N, %) | Pathogen Identification after procedure (X/Y) | Positive Microbiology Results |
|
Percutaneous Endoscopic Debridement and Drainage (PEDD) |
Yang et al., 2007 | Lumbar – 15 (100%) | 13/15 | 86.67% |
| Yang et al., 2008 | Lumbar – 20 (100%) | 18/20 | 90.00% | |
| Fu et al., 2010 | Lumbar – 6 (100%) | 5/6 | 83.33% | |
| Yang et al., 2014 | Lumbar – 32 (100%) | 28/32 | 87.50% | |
| Yang et al., 2014 | Lumbar – 21 (100%) | 19/21 | 90.48% | |
| Wang et al., 2016 | Lumbar – 41 (100%) | 32/41 | 78.05% | |
| Yang et al., 2019 | Lumbar – 20 (100%) | 17/20 | 85.00% | |
|
Fu et al., 2019 |
Lumbar – 37 (100%) |
30/37 |
81.08% |
|
|
CT-Guided Needle Biopsy |
Yang et al., 2008 | Lumbar – 32 (100%) | 15/32 | 46.88% |
| Garg et al., 2014 | Cervical – 1 (1.2%) | 16/84 | 19.05% | |
| Thoracic – 37 (44%) | ||||
| Lumbosacral – 46 (54.8%) | ||||
| Spira et al., 2016 | Thoracic – 11 (32.4%) Lumbar – 23 (67.4%) |
10/34 | 29.41% | |
| Kasalak et al., 2018 | Cervical – 5 (7.8%) Thoracic – 18 (28.1%) Thoracolumbar – 3 (4.7%) Lumbar – 27 (42.2%) Lumbosacral – 11 (17.2%) |
20/64 | 31.25% | |
| Braun et al., 2019 | Not reported | 11/40 | 27.50% | |
| Afshari et al., 2020 | Thoracic – 1 (20%) Lumbar – 3 (60%) Lumbosacral – 1 (20%) |
1/5 | 20.00% | |
| Husseini et al., 2020 | Thoracic – 69 (29%) Lumbar – 172 (71%) |
95/241 | 39.42% | |
|
Wong et al., 2021 |
Cervical – 5 (4.8%) Thoracic – 34 (32.7%) Lumbar – 65 (62.5%) |
53/104 |
50.96% |
|
| Total (PEDD) | 8 studies | Lumbar – 192 (100%) | 162/192 | 84.38% |
| Total (CT) | 8 studies |
Cervical – 11 (1.95%) Thoracic – 170 (30.14%) Thoracolumbar – 3 (0.53%) Lumbar – 322 (57.09%) Lumbosacral – 58 (10.28%) |
221/604 | 36.59% |